Pneumococcal Vaccine Study

Now open in Baton Rouge, LA; Grand Island, NE; and Washington, DC

Streptococcus pneumoniae is one of the leading causes of bacteremia (S. pneumoniae in the blood), bacterial meningitis (infection in the lining around the brain), pneumonia (lung infection), and middle ear infections in infants and young children, and remains a significant cause of disease worldwide.

This research study is to evaluate an investigational vaccine that may increase protection against infections caused by Streptococcus pneumoniae.

Eligible participants…

  • Must be age 42 to 89 days old
  • May receive compensation for time and travel
  • Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.

You can also talk to a Meridian enrollment specialist about this study by calling (712) 639-6200 (NE) or (912) 623-2240 (LA, DC).

Submit your information

Expect Excellence icon - supporting research since 1999

Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services. Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.